Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.91 | 45.57 |
| PEG Ratio (TTM) | 1.67 | 1.01 |
| P/S Ratio (TTM) | 1.51 | 17.12 |
| P/B Ratio (TTM) | 4.31 | 16.75 |
| P/FCF Ratio (TTM) | -16.54 | 40.14 |
| Price to 5YR AVG Earnings Ratio | N/A | 63.04 |
| Price to 5YR AVG FCF Ratio | N/A | 98.76 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -35.68% | -2.56% |
| ROE (TTM) | -75.89% | 10.12% |
| Net Profit Margin (TTM) | -19.31% | 4.50% |
| ROIC 5YR AVG | N/A | 3.39% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.70% | -38.19% | N/A |
| Revenue | 0.69% | 25.27% | N/A |
| Net Income | -18.67% | -6.74% | N/A |
| Cash Flow | -0.49% | -145.50% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.18 | 1.92 |
| Quick Ratio (TTM) | 2.18 | 1.91 |
| D/E Ratio (TTM) | N/A | 0.57 |
| Interest Coverage (TTM) | N/A | 11.84 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 10.66 |
| LTL to 5YR AVG FCF | N/A | 3.74 |
| Shares Outstanding Growth 5YR AVG | N/A | 44.60% |